COVID-19 Strengthens Ties Between UK MHRA & NICE On Access To Innovation
Executive Summary
New partnerships forged between the UK medicines regulator and health technology assessment bodies during COVID-19 have resulted in an improved understanding of the benefits new drugs can bring to the NHS and how to manage their rapid introduction.